Cancer Personalized Medicine 2008

The Cancer Personalized Medicine marketplace represents the paradigm for personalized medicine market evolution and Select Biosciences focuses in this report on the various commercialized cancer predictor tests, their current status, traction in the marketplace, quantitative market opportunities, and the factors that are driving as well as challenging the expansion of this space. Personalized Medicine, especially as it relates to Cancer, is undergoing significant growth and this report focuses in on all the science, market/commercialization, and diagnostic/therapeutics trends—emerging classes of cancer biomarkers such as microRNAs and epigenetics are also examined in this report, as well as the pipeline of RNAi-therapeutics for cancer.

Further Information: http://www.selectbiosciences.com/marketreports/CancerPersMed08.aspx